The following listserv response summaries are now available in the members area (login required):
9) Internet platform with independent drug information for physicians? (GOEG, Austria)
8) Do you have and could share an HTA and / or economic evaluation about the use of adalimumab in psoriatic arthritis? (UCEETS, Argentina)